Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

1(13%)

Results Posted

40%(2 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_4

25%

Ph not_applicable

25%

Ph phase_3

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 3Large-scale testing

3(42.9%)

Phase 4Post-market surveillance

2(28.6%)

N/ANon-phased studies

2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(5)

Terminated(1)

Detailed Status

Completed5

Recruiting1

Terminated1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 4

Trials by Phase

Phase 33 (42.9%)

Phase 42 (28.6%)

N/A2 (28.6%)

Trials by Status

recruiting113%

terminated113%

completed563%

not_yet_recruiting113%

Recent Activity

1 active trials

Showing 5 of 8

recruitingphase_4

Aβ Dynamics in LLMD

NCT05004987

completed

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

NCT00667121

completednot_applicable

Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression

NCT06325605

not_yet_recruitingphase_4

Efficacy of Hydroxyzine for Patients With Panic Disorder

NCT05737511

completedphase_3

Brain Imaging and Treatment Studies of the Night Eating Syndrome

NCT01401595

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT05004987Phase 4

Aβ Dynamics in LLMD

Recruiting

NCT00667121

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Completed

NCT06325605Not Applicable

Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression

Completed

NCT05737511Phase 4

Efficacy of Hydroxyzine for Patients With Panic Disorder

Not Yet Recruiting

NCT01401595Phase 3

Brain Imaging and Treatment Studies of the Night Eating Syndrome

Completed

NCT01894815Phase 3

Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial

Completed

NCT01538693Not Applicable

Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury

Completed

NCT00387348Phase 3

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Terminated

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8